慢性阻塞性肺疾病(COPD)支气管阻塞的重要病理生理机制包括由迷走神经控制的黏液高分泌以及由胆碱能机制诱发的支气管平滑肌张力的增加,因此,抗胆碱治疗已成为其第一选择.中文核心期刊要目总览(PKU)中国科学引文数据库(CSCD)07484-4852
Acetylcholine is the primary parasympathetic neurotransmitter in the airways and an autocrine/paracr...
Background: Inhaled corticosteroid (ICS) with long-acting beta-2 agonists is a well-documented comb...
We assessed the overall efficacy and safety of a long-acting muscarinic antagonist （LAMA） added to a...
目的了解慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)患者肺组织M受体及其亚型的变化。方法采用肺手术切除标本，分为COPD组和对照组，进行放...
近年来,慢性阻塞性肺疾病(COPD)发病率不断上升,病死率逐渐增加,严重威胁着全世界患者的生命健康.由于胆碱能神经及其受体的变化在COPD的发病过程中起重要的作用,因此抗胆碱药物是目前治疗COPD的主...
近年来,有关COPD相关药物的临床研究逐渐增多.支气管舒张剂是目前治疗COPD的基本药物,其中抗胆碱能药物对COPD的治疗作用是研究的热点之一.中文核心期刊要目总览(PKU)中国科技核心期刊(ISTI...
当前治疗慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)的绝大多数药物作用于气道内细胞所表达的受体.因为吸入治疗可以传送药物到关键靶位细胞,并且...
Хроничната обструктивна пулмонална болест (copd) е болна состојба коja се карактеризира со лимитира...
In COPD, the activity of the cholinergic system is increased, which is one of the reasons for the ai...
Introduction: Bronchodilators are the cornerstone of chronic obstructive pulmonary disease (COPD) th...
Paul W Jones Institute for Infection and Immunity, Faculty of Respiratory Medicine, St George’...
Muscarinic receptors are expressed by most cell types and mediate cellular signaling of their natura...
Abstract: Importance of the field. The prevention and relief of symptoms by regular use of bronchodi...
AIM: Aclidinium bromide is a muscarinic antagonist in development for the treatment of chronic obstr...
慢性阻塞件肺疾病(COPD)是可预防及治疗的疾病,COPD患者接受适宜的药物长期治疗,可有效缓解或逆转临床进程.本文就β2受体激动剂、抗胆碱约物、吸入型糖皮质激素,以及COPD的联合治疗作一综述.01...
Acetylcholine is the primary parasympathetic neurotransmitter in the airways and an autocrine/paracr...
Background: Inhaled corticosteroid (ICS) with long-acting beta-2 agonists is a well-documented comb...
We assessed the overall efficacy and safety of a long-acting muscarinic antagonist （LAMA） added to a...
目的了解慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)患者肺组织M受体及其亚型的变化。方法采用肺手术切除标本，分为COPD组和对照组，进行放...
近年来,慢性阻塞性肺疾病(COPD)发病率不断上升,病死率逐渐增加,严重威胁着全世界患者的生命健康.由于胆碱能神经及其受体的变化在COPD的发病过程中起重要的作用,因此抗胆碱药物是目前治疗COPD的主...
近年来,有关COPD相关药物的临床研究逐渐增多.支气管舒张剂是目前治疗COPD的基本药物,其中抗胆碱能药物对COPD的治疗作用是研究的热点之一.中文核心期刊要目总览(PKU)中国科技核心期刊(ISTI...
当前治疗慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)的绝大多数药物作用于气道内细胞所表达的受体.因为吸入治疗可以传送药物到关键靶位细胞,并且...
Хроничната обструктивна пулмонална болест (copd) е болна состојба коja се карактеризира со лимитира...
In COPD, the activity of the cholinergic system is increased, which is one of the reasons for the ai...
Introduction: Bronchodilators are the cornerstone of chronic obstructive pulmonary disease (COPD) th...
Paul W Jones Institute for Infection and Immunity, Faculty of Respiratory Medicine, St George’...
Muscarinic receptors are expressed by most cell types and mediate cellular signaling of their natura...
Abstract: Importance of the field. The prevention and relief of symptoms by regular use of bronchodi...
AIM: Aclidinium bromide is a muscarinic antagonist in development for the treatment of chronic obstr...
慢性阻塞件肺疾病(COPD)是可预防及治疗的疾病,COPD患者接受适宜的药物长期治疗,可有效缓解或逆转临床进程.本文就β2受体激动剂、抗胆碱约物、吸入型糖皮质激素,以及COPD的联合治疗作一综述.01...
Acetylcholine is the primary parasympathetic neurotransmitter in the airways and an autocrine/paracr...
Background: Inhaled corticosteroid (ICS) with long-acting beta-2 agonists is a well-documented comb...
We assessed the overall efficacy and safety of a long-acting muscarinic antagonist （LAMA） added to a...
DOI
Add to ORKG